ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST)

316,31
0,00
(0,00%)
Geschlossen 04 Juni 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

West Pharmaceutical Services Inc (WST) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-12Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer-219,2668,42kDerivative Exercise and Sale312,07613,00-
2026-05-12Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer550,330,00Derivative Exercise and Retained Stock-613,00878,17%
2026-04-27Ms. Annette F. FavoriteChief HR Officer & Senior VP-2,82k624,62kDerivative Exercise and Sale83,47 - 305,2016,83k-
2026-04-27Mr. Chad R. WintersVP of Finance & CAO-896,00114,19kDerivative Exercise and Sale173,22 - 300,671,52k-
2026-02-20Mr. Rudy J. PoussotSVP of Strategy & Corporate Development253,840,00Derivative Exercise and Retained Stock-561,0082,64%
2026-02-20Mr. Rudy J. PoussotSVP of Strategy & Corporate Development-129,5531,24kDerivative Exercise and Sale241,12561,00-
2026-02-20Mr. Charles WitherspoonVP & Treasurer38,150,00Derivative Exercise and Retained Stock-1,41k2,79%
2026-02-20Mr. Charles WitherspoonVP & Treasurer-22,075,32kDerivative Exercise and Sale241,121,41k-
2026-02-20Mr. Chad R. WintersVP of Finance & CAO59,140,00Derivative Exercise and Retained Stock-1,52k4,04%
2026-02-20Mr. Chad R. WintersVP of Finance & CAO-30,187,28kDerivative Exercise and Sale241,121,52k-
2026-02-18Mr. Rudy J. PoussotSVP of Strategy & Corporate Development54,490,00Derivative Exercise and Retained Stock-307,0021,58%
2026-02-18Mr. Rudy J. PoussotSVP of Strategy & Corporate Development-27,816,90kDerivative Exercise and Sale248,26307,00-
2026-02-17Mr. Charles WitherspoonVP & Treasurer-41,5210,10kSale to Issuer243,191,37k-2,94%
2026-02-17Mr. Chad R. WintersVP of Finance & CAO-50,5812,30kSale to Issuer243,191,46k-3,34%
2026-02-17Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO-1,31k317,46kSale to Issuer243,19175,16k-0,74%
2026-02-18Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO745,260,00Derivative Exercise and Retained Stock-175,16k0,43%
2026-02-18Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO-573,55142,39kDerivative Exercise and Sale248,26175,16k-
2026-02-17Ms. Annette F. FavoriteChief HR Officer & Senior VP-150,4436,59kSale to Issuer243,1917,37k-0,86%
2026-02-18Ms. Annette F. FavoriteChief HR Officer & Senior VP99,730,00Derivative Exercise and Retained Stock-17,37k0,58%
2026-02-18Ms. Annette F. FavoriteChief HR Officer & Senior VP-35,768,88kDerivative Exercise and Sale248,2617,37k-
2026-02-11Mr. Robert W. McMahonSenior VP & CFO2,98k0,00Derivative Exercise and Retained Stock-2,98k-
2026-02-11Mr. Robert W. McMahonSenior VP & CFO-1,25k307,71kDerivative Exercise and Sale246,162,98k-